Xenon Pharmaceuticals Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Xenon Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q2 2024.
Xenon Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$69.1M, a 24.2% decline year-over-year.
Xenon Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$238M, a 27.6% decline year-over-year.
Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$214M, a 65.8% decline from 2022.
Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$129M, a 63.5% decline from 2021.
Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$79M, a 152% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$238M	-$69.1M	-$13.5M	-24.2%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$224M	-$59M	-$9.99M	-20.4%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$214M	-$53.7M	-$10.4M	-23.9%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-29
Q3 2023	-$204M	-$55.7M	-$17.6M	-46%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	-$186M	-$55.6M	-$25.3M	-83.5%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	-$161M	-$49.1M	-$31.7M	-182%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$129M	-$43.3M	-$18.5M	-74.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-29
Q3 2022	-$111M	-$38.1M	-$22.5M	-144%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	-$88.1M	-$30.3M	-$7.82M	-34.7%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	-$80.3M	-$17.4M	-$1.31M	-8.16%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	-$79M	-$24.8M	-$11.9M	-92.2%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-29
Q3 2021	-$67.1M	-$15.6M	-$5.9M	-60.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	-$61.2M	-$22.5M	-$21.9M	-3383%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	-$39.3M	-$16.1M	-$8.03M	-99.9%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	-$31.3M	-$12.9M	-$1.33M	-11.4%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-01
Q3 2020	-$30M	-$9.7M	-$748K	-8.36%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$29.2M	-$646K	+$9.87M	+93.9%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11
Q1 2020	-$39.1M	-$8.03M	+$3.73M	+31.7%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	-$42.8M	-$11.6M	-$3.14M	-37.2%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-01
Q3 2019	-$39.7M	-$8.95M	+$5.24M	+36.9%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	-$44.9M	-$10.5M	-$2.92M	-38.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	-$42M	-$11.8M	-$3.95M	-50.6%	Jan 1, 2019	Mar 31, 2019	10-Q/A	2020-05-26
Q4 2018	-$38M	-$8.45M	-$403K	-5.01%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-09
Q3 2018	-$37.6M	-$14.2M	-$5.54M	-64.1%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	-$32.1M	-$7.59M	+$299K	+3.79%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-06
Q1 2018	-$32.4M	-$7.81M	+$181K	+2.27%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-07
Q4 2017	-$32.6M	-$8.05M	-$2.59M	-47.4%	Oct 1, 2017	Dec 31, 2017	10-K	2018-03-07
Q3 2017	-$30M	-$8.64M	-$1.31M	-17.9%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-06
Q2 2017	-$28.7M	-$7.89M	-$1.53M	-24%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-07
Q1 2017	-$27.1M	-$7.99M	-$2.33M	-41.2%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-08
Q4 2016	-$24.8M	-$5.46M	-$2.86M	-110%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-07
Q3 2016	-$22M	-$7.33M	-$6.51M	-794%	Jul 1, 2016	Sep 30, 2016	10-K	2018-03-07
Q2 2016	-$15.4M	-$6.37M	-$6.57M	-3299%	Apr 1, 2016	Jun 30, 2016	10-K	2018-03-07
Q1 2016	-$8.88M	-$5.66M	+$479K	+7.81%	Jan 1, 2016	Mar 31, 2016	10-K	2018-03-07
Q4 2015	-$9.36M	-$2.6M	-$2.64M	-7537%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-08
Q3 2015	-$6.72M	-$820K	-$9.48M	-109%	Jul 1, 2015	Sep 30, 2015	10-K	2017-03-08
Q2 2015	$2.76M	$199K	-$1.18M	-85.6%	Apr 1, 2015	Jun 30, 2015	10-K	2017-03-08
Q1 2015	$3.94M	-$6.14M	-$7.17M	-695%	Jan 1, 2015	Mar 31, 2015	10-K	2017-03-08
Q4 2014	$11.1M	$35K	-$1.98M	-98.3%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-08
Q3 2014	$13.1M	$8.66M	+$2.14M	+32.9%	Jul 1, 2014	Sep 30, 2014	10-K	2016-03-08
Q2 2014	$10.9M	$1.38M	+$2.15M		Apr 1, 2014	Jun 30, 2014	10-K	2016-03-08
Q1 2014	$8.8M	$1.03M	-$912K	-46.9%	Jan 1, 2014	Mar 31, 2014	10-K	2016-03-08
Q4 2013	$9.71M	$2.02M			Oct 1, 2013	Dec 31, 2013	10-K	2015-03-12
Q3 2013		$6.52M			Jul 1, 2013	Sep 30, 2013	10-K	2015-03-12
Q2 2013		-$770K			Apr 1, 2013	Jun 30, 2013	10-K	2015-03-12
Q1 2013		$1.94M			Jan 1, 2013	Mar 31, 2013	10-K	2015-03-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.